Indoco Remedies Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indoco Remedies Ltd. on BSE

Load latest

Indoco Remedies Ltd.

22 May 2025

325.15

-1.34%

Result

Indoco Remedies Ltd - 532612 - Financial Results For The Year Ended 31St March, 2025

BSE India

Approval of Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2025

pdf

Indoco Remedies Ltd.

22 May 2025

325.15

-1.34%

Board Meeting

Indoco Remedies Ltd - 532612 - Board Meeting Outcome for Financial Results For The Year Ended …

BSE India

Pursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ("Listing Regulations"), we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 22nd May, 2025 has inter-alia considered and approved the following.1. Audited Financial Results (Consolidated and Standalone) for the quarter and year ended 31st March, 2025 and Auditors' Reports with unmodified opinion on the aforesaid Audited Financial Results.2. Subject to the approval of the Members at the ensuing 78th Annual General Meeting, recommended a Dividend of Rs. 0.20 per equity share on face value of Rs. 2/- for the financial year 2024-2025.

pdf

Indoco Remedies Ltd.

15 May 2025

325.15

-1.34%

Company Update

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of Earnings Conference Call on Audited Financial Results for the Quarter and Year ended 31st March, 2025

pdf

Indoco Remedies Ltd.

15 May 2025

325.15

-1.34%

Company Update

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of Earnings Conference Call on Audited Financial Results for quarter and Year ended 31st March, 2025

pdf

Indoco Remedies Ltd.

14 May 2025

325.15

-1.34%

Board Meeting

Indoco Remedies Ltd - 532612 - Board Meeting Intimation for Audited Results & Dividend

BSE India

Indoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 ,inter alia, to consider and approve 1. The Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2025. 2. To recommend a final dividend, if any for the financial year ending 31st March, 2025.

pdf

Indoco Remedies Ltd.

07 Apr 2025, 05:01PM

325.15

-1.34%

Company Update

Indoco Remedies Ltd - 532612 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Attached the Certificate issued by MUFG Intime India Pvt Ltd, Registrar & Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI (D&P) Regulations,2018 for the quarter ended 31-03-2025.

pdf

Indoco Remedies Ltd.

28 Mar 2025

325.15

-1.34%

SAST

Indoco Remedies Ltd - 532612 - Closure of Trading Window

BSE India

Intimation regarding Closure of Trading Window

pdf

Indoco Remedies Ltd.

27 Mar 2025

325.15

-1.34%

Company Update

Indoco Remedies Ltd - 532612 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations,2015 (Listing …

BSE India

The Company has received an Assessment Order u/s 143(3) dated 26-03-2025 for Assessment year 2023-24 from Assessment Unit Income tax Department.

pdf

Indoco Remedies Ltd.

25 Mar 2025

325.15

-1.34%

Company Update

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

In compliance with Regulation 8(2) of SEBI (PIT) Regulations,2015, it is to inform that the Board of Directors of the Company in their meeting held on 25-03-2025 has adopted the revised Code of Conduct for Prevention of Insider Trading & Code of Practices and Procedures for Fair Disclosure of UPSI

pdf

Indoco Remedies Ltd.

25 Mar 2025

325.15

-1.34%

Company Update

Indoco Remedies Ltd - 532612 - Intimation Of Appointment Of Cost Auditor Of The Company Pursuant …

BSE India

The Board of Directors of the Company at their meeting held on 25-03-2025 has interalia considered and approved the following: Reappointment of M/s. Joshi Apte & Associates, Cost Accountants, as the Cost Auditors of the Company for the financial year 2025-2026

pdf

Is Indoco Remedies Ltd. worth buying?

60 Votes:

Buy 75.0%

Sell 15.0%

Hold 10.0%

RESEARCH REPORTS

Not Rated SEE REPORTS >

pdf

Accumulate SEE REPORTS >

pdf